Robot-Assisted Cardiac Surgery Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 900.0 million
Estimated Base Value
2035 Forecast
US$ 4.5 billion
Projected Market Value
CAGR 2026–2035
17.5%
Compound Annual Growth
Largest Segment
Surgical Robotic Systems
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
Asia Pacific
Fastest Growing Region
Latin America
Top Country
United States
By Market Share
Largest market
Key Players
Stereotaxis
Emerging Players
Distalmotion, Avatera Medical GmbH
Robot-Assisted Cardiac Surgery Market Overview
The Robot-Assisted Cardiac Surgery Market includes medical device technologies and platforms designed to assist surgeons in performing cardiovascular operations with enhanced precision, control, and visualization. This market covers advanced robotic systems, specialized instruments, and integrated software used for minimally invasive cardiac procedures, such as coronary artery bypass grafting (CABG), valve repair/replacement, and congenital heart defect repair. It encompasses the sales, servicing, and technological advancements of these robotic platforms, aiming to improve patient outcomes through reduced invasiveness, shorter hospital stays, and faster recovery times compared to traditional open-heart surgery. Buyers include hospitals, ambulatory surgical centers, specialty clinics, academic and research institutes, cardiac catheterization labs, and government healthcare facilities.
The market for robot-assisted cardiac surgery is estimated at $900.0 Mn in 2025 and is forecast to reach $4.5 Bn in 2035, growing at a CAGR of 17.5% from 2025 to 2035. Growth is driven by the rising global incidence of cardiovascular diseases requiring surgery, increased demand for minimally invasive surgical procedures, and advancements in robotic technology improving precision and safety. Enhanced patient outcomes and shorter hospital stays also contribute to demand. However, high initial investment and maintenance costs, extensive surgeon training requirements, and limited reimbursement policies are factors that restrain market expansion.
The market is segmented by Type (Surgical Robotic Systems, Surgical Instruments, Surgical Accessories, Software, Maintenance Services, Training Services, Upgrades and Updates, Others), by Application (Coronary Artery Bypass Grafting, Mitral Valve Repair and Replacement, Aortic Valve Repair and Replacement, Atrial Septal Defect Repair, Ventricular Septal Defect Repair, Cardiac Tumor Resection, Electrophysiology Procedures, Others), by Technology (Telemanipulation Systems, Image-Guided Systems, Computer-Assisted Navigation Systems, Artificial Intelligence, Haptic Feedback Systems, High-Definition 3D Vision Systems, Robotic Arm Assisted Systems, Others), by End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Academic and Research Institutes, Cardiac Catheterization Labs, Government Healthcare Facilities, Private Hospitals, Others), and by Component (Robotic Arms, Control Consoles, Vision Systems, End-Effectors, Software, Energy Systems, Patient Cart Systems, Others). Geographically, the market is served across Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Leading companies include Stereotaxis, Robocath, Tomoaki Surgical, Shanghai MicroPort MedBot, CMR Surgical, Asensus Surgical, Medrobotics, Moon Surgical, Vicarious Surgical, Medical Microinstruments (MMI SpA), Titan Medical, and Virtual Incision. The full report covers global market analysis across key geographic regions, focusing on dedicated robotic platforms for cardiac surgical applications, with a market forecast and trend analysis covering 2025-2035.
Market Definition & Overview
The Robot-Assisted Cardiac Surgery Market includes medical device technologies and platforms designed to assist surgeons in performing cardiovascular operations with enhanced precision, control, and visualization. This market covers the advanced robotic systems, specialized instruments, and integrated software used for minimally invasive cardiac procedures, such as coronary artery bypass grafting (CABG), valve repair/replacement, and congenital heart defect repair. It encompasses the sales, servicing, and technological advancements of these robotic platforms, aiming to improve patient outcomes through reduced invasiveness, shorter hospital stays, and faster recovery times compared to traditional open-heart surgery.
Scope
- Global market analysis across key geographic regions.
- Focus on dedicated robotic platforms for cardiac surgical applications.
- Market forecast and trend analysis covering 2025-2035.
- Segmentation by end-user, including hospitals and specialty cardiac clinics.
Inclusions
- Sales and leasing of robotic surgical systems for cardiac procedures.
- Specialized robotic instruments and end-effectors for cardiac surgery.
- Advanced 3D visualization and imaging systems integrated with cardiac robots.
- Consumables and disposable accessories for robot-assisted cardiac surgery.
- Software solutions and navigation technologies for cardiac surgical robots.
- Post-sales support, maintenance, and training services for these systems.
Exclusions
- Traditional open-heart surgery instrumentation and techniques.
- Robotic systems designed solely for general surgery or other non-cardiac specialties.
- Cardiac support devices and artificial hearts without robotic surgical integration.
- Diagnostic imaging equipment not directly part of robotic surgical platforms.
- Out-of-scope geographies not covered in the global market study.
Market Size Forecast
Executive Summary
• The Robot-Assisted Cardiac Surgery market is valued at $900.0 Mn in 2025 and is forecast to reach $4.5 Bn by 2035, reflecting a robust CAGR of 17.5% as demand accelerates across every major segment and region over the ten-year outlook.
• Surgical Robotic Systems leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at XX.X%, while Emerging Areas is expanding the fastest at a XX.X% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intensifying competitive dynamics are driving strategic consolidations and partnerships, especially for specialized robotic platforms, as established players seek to dominate emerging minimally invasive cardiac procedure segments globally.
• Technological breakthroughs in AI-driven precision and enhanced haptics are significantly expanding addressable patient populations, accelerating adoption across diverse geographies and complex cardiac surgery indications, notably for mitral valve repair.
• Evolving global regulatory frameworks and favorable reimbursement policies are pivotal catalysts, de-risking significant investment for new market entrants and facilitating broader adoption in both mature and emerging healthcare systems.
• Regional strategic priorities are shifting, with robust growth in Asia-Pacific and Latin America fueled by rising healthcare infrastructure investment and surgeon training, while mature markets focus on platform optimization.
• Significant venture capital and corporate investment is increasingly targeting next-generation, more affordable robotic systems and localized supply chain solutions to enhance accessibility and market penetration worldwide.
• Future market expansion hinges on overcoming cost barriers and expanding procedural versatility beyond current indications, positioning hybrid robotic-imaging solutions as key disruptors that reshape clinical practice paradigms.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Valuation
The robot-assisted cardiac surgery market was valued at $900.0 million in the base year, reflecting its substantial initial footprint.
Robust Growth Projection
The market is projected to reach $4.5 billion by the forecast year, indicating significant expansion and adoption.
High CAGR Sustained
A Compound Annual Growth Rate (CAGR) of 17.5% underscores the rapid advancements and increasing demand for robot-assisted cardiac procedures.
North American Dominance
North America is anticipated to be the leading region, driven by advanced healthcare infrastructure and high investment in medical technologies.
CABG Segment Leadership
The Coronary Artery Bypass Grafting (CABG) segment is expected to remain the dominant application, owing to the high prevalence of coronary heart disease.
Advancing Technology Trend
A key trend involves the continuous integration of artificial intelligence and enhanced imaging systems, improving surgical precision and patient outcomes.
Market Dynamics
Market Trends
- Increasing adoption of AI and machine learning in surgical robots.
- Miniaturization of robotic instruments for less invasive procedures.
- Growing preference for hybrid operating rooms integrating robotics.
- Development of new robotic platforms for specialized cardiac surgeries.
Growth Drivers
- Rising global incidence of cardiovascular diseases requiring surgery.
- Increased demand for minimally invasive surgical procedures.
- Advancements in robotic technology improving precision and safety.
- Enhanced patient outcomes and shorter hospital stays post-surgery.
Restraints
- High initial investment and maintenance costs hinder widespread adoption.
- Extensive surgeon training and a steep learning curve are significant barriers.
- Limited reimbursement policies can restrict market penetration and hospital revenue.
- Potential for technical complications and ethical concerns raises user apprehension.
Opportunities
- Expansion into emerging economies with growing healthcare infrastructure.
- Development of new surgical applications beyond traditional procedures.
- Strategic collaborations between robot manufacturers and hospitals.
- Increased investment in training and education for robotic surgeons.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Surgical Robotic SystemsSurgical InstrumentsSurgical AccessoriesSoftwareMaintenance ServicesTraining ServicesUpgrades and UpdatesOthers |
| By Application | Coronary Artery Bypass GraftingMitral Valve Repair and ReplacementAortic Valve Repair and ReplacementAtrial Septal Defect RepairVentricular Septal Defect RepairCardiac Tumor ResectionElectrophysiology ProceduresOthers |
| By Technology | Telemanipulation SystemsImage-Guided SystemsComputer-Assisted Navigation SystemsArtificial IntelligenceHaptic Feedback SystemsHigh-Definition 3D Vision SystemsRobotic Arm Assisted SystemsOthers |
| By End-User | HospitalsAmbulatory Surgical CentersSpecialty ClinicsAcademic and Research InstitutesCardiac Catheterization LabsGovernment Healthcare FacilitiesPrivate HospitalsOthers |
| By Component | Robotic ArmsControl ConsolesVision SystemsEnd-EffectorsSoftwareEnergy SystemsPatient Cart SystemsOthers |
Regional Analysis
- North America leads the robot-assisted cardiac surgery market, driven by advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and significant R&D investments. Strong reimbursement policies and early adoption of robotic surgical systems further consolidate its dominant position.
- The Asia-Pacific region is the fastest-growing market segment, primarily due to increasing healthcare expenditure, a rapidly aging population, and rising awareness of minimally invasive procedures. Governments are actively investing in modernizing healthcare infrastructure and advanced medical technologies.
- In Europe, a noteworthy trend involves the increasing focus on cost-efficiency and improving patient outcomes through centralized procurement and expanded access to advanced robotic platforms. This initiative aims to optimize hospital budgets while maintaining high standards of care.
| Asia PacificXX.X% | North AmericaXX.X% | EuropeXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Characterized by high adoption rates of advanced medical technologies, substantial R&D investments, and a robust reimbursement landscape.
- The presence of key market players and a high prevalence of cardiovascular conditions also drive market growth.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Experiences strong growth driven by increasing healthcare access, rising awareness of advanced surgical options, and a growing medical tourism sector.
- Economic development and investments in private healthcare facilities further support market expansion.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Benefits from well-established healthcare infrastructure and a strong focus on innovative surgical techniques and patient outcomes.
- Strict regulatory frameworks and an aging population contribute to steady growth and adoption of sophisticated robotic systems.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Dominated by growing healthcare expenditure, increasing incidence of cardiovascular diseases, and technological advancements in countries like China, Japan, and India.
- Local manufacturing and government support also contribute to its significant market presence.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Market expansion is primarily fueled by heavy investments in healthcare infrastructure in the GCC countries and a rising burden of chronic diseases.
- Limited access and infrastructure challenges in other African regions temper overall regional growth.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The United States leads the market due to its advanced healthcare infrastructure, high adoption of cutting-edge robotic surgical systems, and significant R&D investment in medical technologies. A large patient pool and favorable reimbursement policies further drive market growth. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | As the largest economy in South America, Brazil shows strong potential for robotic cardiac surgery due to a large population, a rising middle class, and increasing private healthcare spending. A growing number of specialized cardiac centers are adopting robotic systems. |
| 3 | Germany | US$ XX.X Mn | XX.X% | Germany stands out in Europe with its robust healthcare system, high technological adoption rates, and strong emphasis on medical innovation and research. A significant number of cardiac centers are equipped with robotic platforms, driving steady market growth. |
| 4 | China | US$ XX.X Mn | XX.X% | China represents a high-growth market due to its massive patient pool, rapidly improving healthcare infrastructure, and significant government investment in advanced medical technologies. Localized manufacturing and rising disposable incomes further accelerate adoption. |
| 5 | United Arab Emirates | US$ XX.X Mn | XX.X% | The UAE is a leading market in the Middle East due to high per capita healthcare expenditure, a strong focus on medical tourism, and rapid adoption of cutting-edge medical technologies. Significant government investment in advanced hospital infrastructure further fuels this growth. |
Countries Covered (25)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, United Kingdom, France, Italy, Spain, Russia, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Malaysia, Rest of Asia Pacific, United Arab Emirates, Saudi Arabia, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Stereotaxis | XX.X% | Focus on advanced robotic magnetic navigation systems for electrophysiology, enhancing precision and safety in complex arrhythmia procedures. | — | — | Niobe ESV-CathOdyssey Solution+1 |
| 2 | Robocath | XX.X% | Develop and commercialize robotic solutions for interventional cardiology and peripheral vascular procedures, aiming to improve physician safety and procedural reliability. | — | — | R-OneM-OneX-One |
| 3 | Tomoaki Surgical | XX.X% | Focus on developing next-generation surgical robotics with advanced imaging and haptic feedback capabilities for a broad range of minimally invasive surgeries. | — | — | Robotic Surgical System |
| 4 | Shanghai MicroPort MedBot | XX.X% | Provide comprehensive intelligent surgical robotic solutions for multiple specialties, leveraging proprietary technology to address the rapidly growing Chinese and international markets. | — | — | Toumai Laparoscopic Surgical RobotSkyWalker Joint Replacement RobotHonghu Laparoscopic Surgical Robot |
| 5 | CMR Surgical | XX.X% | Deliver a versatile, cost-effective, and modular robotic system to make minimally invasive surgery accessible to more patients globally. | — | — | Versius Surgical Robotic SystemVersius ConsoleVersius Instrument range |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Stereotaxis, Robocath, Tomoaki Surgical, Shanghai MicroPort MedBot, CMR Surgical, Asensus Surgical, Medrobotics, Moon Surgical, Vicarious Surgical, Medical Microinstruments (MMI SpA), Titan Medical, Virtual Incision, Quantum Surgical, Meere Company, Riverfield Inc., EndoMaster Co., Ltd., Rob Surgical, Shenzhen Jihun Medical Technology Co., Ltd., Tianjin Saizhi Technology Co., Ltd., HD Surgical
The global Robot-Assisted Cardiac Surgery market features a competitive landscape led by Stereotaxis, Robocath, Tomoaki Surgical, Shanghai MicroPort MedBot, CMR Surgical, and Asensus Surgical, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
Stereotaxis
Robocath
Tomoaki Surgical
Shanghai MicroPort MedBot
CMR Surgical
Asensus Surgical
Medrobotics
Moon Surgical
Vicarious Surgical
Medical Microinstruments (MMI SpA)
Titan Medical
Virtual Incision
Quantum Surgical
Meere Company
Riverfield Inc.
EndoMaster Co., Ltd.
Rob Surgical
Shenzhen Jihun Medical Technology Co., Ltd.
Tianjin Saizhi Technology Co., Ltd.
HD Surgical
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Major Robotics Firm Unveils Next-Gen Cardiac Surgery Platform
A leading medical robotics company launched its new robotic-assisted system specifically designed for intricate cardiac procedures, promising enhanced precision, improved visualization, and a reduced learning curve for surgeons.
MedTech Giant Acquires Cardiac Robotics Innovator for US$ XX.X
A global medical technology conglomerate announced its acquisition of a specialized startup focusing on AI-powered robotic tools for minimally invasive cardiac valve repair, signaling a strategic move to bolster its presence in the high-growth segment.
Strategic Partnership Formed for Advanced Cardiac Robotics Training
A prominent robotic surgery platform provider entered into a partnership with a major university hospital network to establish centers of excellence for surgeon training and clinical research in robot-assisted cardiac interventions.
Leading Robotic Surgery Manufacturer Expands Production Facility
Driven by rising global demand, a key player in the surgical robotics market announced a significant expansion of its manufacturing and R&D facilities to scale up production of its dedicated cardiac surgery platforms and support services.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $900.0 Mn |
| Market Size (Forecast) | $4.5 Bn |
| CAGR | 17.5% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 25 Countries |
| Segments Covered | 5 Segments, 40 Sub-segments |
| Companies Profiled | 32 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the Robot-Assisted Cardiac Surgery Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
VP, Corporate Strategy
Industrial manufacturing company
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Director, Investment Research
Private equity firm
“We now use these reports in every planning cycle. The regional granularity, and the same numbers across the report, the dashboard and the Excel, save our team real time.”
Head of Market Intelligence
Specialty chemicals company
Frequently Asked Questions
Common questions about this report and our research
The Robot-Assisted Cardiac Surgery market is estimated at $900.0 Mn in 2025.
The Robot-Assisted Cardiac Surgery market is forecast to grow at a CAGR of 17.5% from 2025 to 2035.
Main segments include Surgical Robotic Systems, Coronary Artery Bypass Grafting, Telemanipulation Systems, Hospitals, and Robotic Arms. Other segments cover various types, applications, technologies, end-users, and components.
Leading companies include Stereotaxis, Robocath, Tomoaki Surgical, Shanghai MicroPort MedBot, CMR Surgical, Asensus Surgical, Medrobotics, Moon Surgical, Vicarious Surgical, Medical Microinstruments (MMI SpA), Titan Medical, and Virtual Incision.
The report covers global market analysis across key geographic regions, focusing on dedicated robotic platforms for cardiac surgical applications. It includes a market forecast and trend analysis covering 2025-2035, segmented by end-user, including hospitals and specialty cardiac clinics.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
Robot-Assisted Orthopedic Surgery Market
$3.0 Bn in 2025 · 15.1% CAGR
Robot-Assisted Spine Surgery Market
$2.0 Bn in 2025 · 16.9% CAGR
Robot-Assisted Neurosurgery Market
$1.4 Bn in 2025 · 16.8% CAGR
Robot-Assisted Urology Market
$3.5 Bn in 2025 · 11.9% CAGR
Remote Surgery Platform Market
$386.7 Mn in 2025 · 24.6% CAGR
AI Precision Surgery Market
$1.9 Bn in 2025 · 18.6% CAGR
Cardiac Monitoring Devices Market
$6.4 Bn in 2025 · 6.0% CAGR
Cardiac Rhythm Management Market
$22.6 Bn in 2025 · 5.1% CAGR